Navarese EP, Gurbel PA, Andreotti F, Kolodziejczak MM, Palmer SC, Dias S, Buffon A, Kubica J, Kowalewski M, Jadczyk T, Laskiewicz M, Jedrzejek M, Brockmeyer M, Strippoli GFM. Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures: a systematic review and network meta-analysis. PLoS One. 2017;12(2): e0168726. doi: 10.1371/journal.pone.0168726.

Hill P, Cross NB, Barnett ANR, Palmer SC, Webster AC. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Cochrane Database of Systematic Reviews 2017:CD004759.

Palmer SC, Tunnicliffe DJ, Singh-Grewal D, Mavridis D, Tonelli M, Johnson DW, Craig JC, Tong A, Strippoli GFM. Induction and maintenance immunosuppression treatment of proliferative lupus nephritis: A network meta-analysis of randomized trials. American Journal of Kidney Diseases 2017 Feb 20. pii: S0272-6386(17)30036-7. doi: 10.1053/j.ajkd.2016.12.008.

Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GFM. Dietary patterns for adults with chronic kidney disease. Cochrane Database of Systematic Reviews 2017. Accepted for publication.

Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, Maggo J, Gray V, De Berardis G, Ruospo M, Natale P, Saglimbene V, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque L, Lloyd A, Ahmad N, Liu Y, Tiv S, Wiebe N, Strippoli GF. Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis. Journal of the American Medical Association 2016 July 19;316(3):313-324.

Badve SV, Palmer SC, Hawley CM, Pascoe EM, Strippoli GF, Johnson DW. Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials. Nephrology Dialysis Transplantation. 2016;31(9):1425-36.

Kelly J, Palmer SC, Wai SN, Ruospo M, Carrero J-J, Campbell KL, Strippoli GFM. Healthy dietary patterns, mortality, and end-stage kidney disease in CKD: A meta-analysis of cohort studies. Clinical Journal of the American Society of Nephrology. 2016; published ahead of print December 8, 2016, doi: 10.2215/CJN.06190616.

Palmer SC, Gardner S, Tonelli M, Mavridis D, Johnson DW, Craig JC, French R, Ruospo M, Strippoli GF. Phosphate binding agents in adults with CKD: A network meta-analysis of randomized trials. American Journal of Kidney Diseases 2016 Jul 22. doi: 10.1053/j.ajkd.2016.05.015.

Badve SV, Palmer SC, Strippoli GFM, Roberts MA, Teixeira-Pinto A, Boudville N, Cass A, Hawley CM, Hiremath SS, Pascoe EM, Perkovic V, Whalley GA, Craig JC, David W Johnson. The validity of left ventricular mass as a surrogate end point for all-cause and cardiovascular mortality outcomes in people with CKD: A systematic review and meta-analysis. American Journal of Kidney Diseases 2016;68(4):554-63.

O’Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, Parker P, Whiteley W, Strippoli G, Palmer S, Craig JC, Webster AC. Cognition in people with end-stage kidney disease treated with hemodialysis: a systematic review and meta-analysis.  American Journal of Kidney Diseases 2016;67(6):925-935.

Palmer SC, Natale P, Ruospo M, Saglimbene VM, Rabindranath KS, Craig JC, Strippoli GFM. Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis. Cochrane Database of Systematic Reviews 2016, Issue 5. Art. No.: CD004541. DOI: 10.1002/14651858.cd004541.pub3.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GFM. Pre-emptive correction of arteriovenous access stenosis: systematic review and meta-analysis of randomized controlled trials. American Journal of Kidney Diseases 2016;67(3):446-60.

Palmer SC, Mavridis D, Navarese E, Craig JC, Tonelli M, Salanti G, Wiebe N, Ruospo M, Wheeler DC, Strippoli GFM. Comparative efficacy and safety of blood pressure lowering agents in adults with diabetes and kidney disease: A network meta-analysis. The Lancet 2015; 385(9982):2047-2056 [with editorial].

Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF. Association of drug effects on serum parathyroid hormone, phosphorus, and calcium levels with mortality in CKD: A meta-analysis. American Journal of Kidney Diseases 2015; 66(6):962-971.

Kaminski MR, Raspovic A, McMahon LP, Strippoli SC, Ruospo M, Dallimore S, Mandorf KB. Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis: A systematic review and meta-analysis. Nephrology Dialysis Transplantation 2015;30(10):1747-1766.

Bolignano D, Palmer SC, Ruospo M, Zoccali C, Craig JC, Strippoli GF. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database of Systematic Reviews 2015;7:CD010294.

Lo P, Sharma A, Craig JC, Wyburn K, Lim W, Palmer SC, Strippoli GF, Wong G. Preconditioning therapy in ABO-incompatible living kidney transplantation: A systematic review and meta-analysis. Transplantation 100(4):933-42.

Vecchio M, Bonarba B, Palmer SC, Craig JC, Ruospo M, Samuels JA, Molony DA, Schena FP, Strippoli GF. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database of Systematic Reviews 2015;8:CD003965.

Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database of Systematic Reviews 2014 Dec 9;12. doi: 10.1002/14651858.CD006254.pub2. Epub 2014 Dec 9.

Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2014 Dec 8;12:CD010590. doi: 10.1002/14651858.CD010590.pub2.

Palmer SC, Palmer AR, Craig JC, Johnson DW, Stroumza P, Frantzen L, Leal M, Hoischen S, Hegbrant J, Strippoli GF. Home versus in-centre haemodialysis for end-stage kidney disease. Cochrane Database of Systematic Reviews 2014 Nov 20;11:CD009535. doi: 10.1002/14651858.CD009535.pub2.

Tong A, Rangan GK, Ruospo M, Saglimbene V, Strippoli GFM, Palmer S, Tunnicliffe D, Craig JC. A painful inheritance – patient perspectives on living with polycystic kidney disease: thematic synthesis of qualitative research. Nephrology Dialysis Transplantation 2015;30(5):790-800.

Walker R, Hanson CS, Palmer SC, Howard K, Morton RL, Marshall MR, Tong A. Patient and caregiver perspectives on home hemodialysis: A systematic review. American Journal of Kidney Diseases 2015;65(3):451-463.

Palmer SC, Hanson CS, Craig JC, Strippoli GFM, Ruospo M, Campbell K, Johnson DW, Tong A. Dietary and fluid restrictions in CKD: A thematic synthesis of patient views from qualitative studies. American Journal of Kidney Diseases 2015;65(4):559-573.

Pickering JW, James MT, Palmer SC. Acute kidney injury and prognosis after cardiopulmonary bypass: a meta-analysis of cohort studies. American Journal of Kidney Diseases 2015;65(2):283-293.

Casey JR, Hanson CS, Winkelmayer WC, Craig JC, Palmer S, Strippoli GFM, Tong A. Anything but a simple surgical procedure: a systematic review of patients’ perspectives on vascular access for hemodialysis. American Journal of Kidney Diseases 2014; 64(6):937-53.

Kabani R, Quinn RR, Palmer S, Lewin AM, Yilmaz S, Tibbles LA, Lorenzetti DL, Strippoli GFM, McLaughlin K, Ravani P. Risk of death following kidney allograft failure: a systematic review and meta-analysis of cohort studies. Nephrology Dialysis Transplantation 2014; 29(9):1778-86.

Bolignano D, Palmer SC, Navaneethan SD, Strippoli GFM. Aldosterone antagonists for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD007004. DOI: 10.1002/14651858.CD007004.pub3.

Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Cross NB, Strippoli GFM. Treatment for peritoneal dialysis associated peritonitis. Cochrane Database of Systematic Reviews 2014, Issue 4. Art No.: CD005284. DOI: 10.1002/14651858.CD005284.pub3.

Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GFM. Darbepoetin for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews 2014 Issue 3 Art No.: CD009297. DOI: 10.1002/1461858.CD009297.pub2.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews 2014 May 31;(50:CD007784. DOI: 10.1002/14651858. .

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegrant J, Strippoli GFM. HMG CoA reductase inhibitors (statins) for kidney transplant recipients (Review). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD005019. DOI: 10.1002/14651858.CD005019.pub4.

Palmer SC, Navaneethan SD, Craig JC, Perkovic V, Johnson DW, Nigwekar SU, Hegbrant J, Strippoli GF. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews 2014 Jan 28;1:CD005019.

Nistor I,* Palmer SC,* Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GFM. Convective versus diffusive therapies for chronic kidney failure: An updated systematic review of randomized trials. American Journal of Kidney Diseases 2014; 63(6):954-967. Impact factor: 5.15 *Equal first authorship.

Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW. Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrology Dialysis Transplantation 2014;29(2):406-13.

Ruospo M, Palmer S, Craig JC, Gentile G, Johnson DW, Ford P, Tonelli M, Petruzzi M, De Benedictis M, Strippoli GFM. Prevalence and severity of oral disease in adults with chronic kidney disease: A systematic review of observational studies. Nephrology Dialysis Transplantation 2014; 29(2):364-75.

Palmer SC, Nistor I, Craig JC, Pellegrini F, Messa P, Tonelli M, Covic A, Strippoli GFM. Calcimimetic agents in people with chronic kidney disease: A cumulative meta-analysis of randomized controlled trials. PLoS Medicine 2013;10(4):e1001436.

Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, Pannu NI, Thomas C, Hemmelgarn BR, Craig JC, Manns B, Tonelli M, Strippoli GFM, James MT. Association between hemodialysis vascular access type and clinical outcomes: Meta-analysis of cohort studies. Journal of the American Society of Nephrology 2013;24(3):465-73.

Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Fishbane S, Strippoli GFM. Prevalence of depression in chronic kidney disease: Systematic review and meta-analysis of observational studies. Kidney International 2013; 84(1):179-91.

Palmer SC, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, Pellegrini F, Saglimbene V, Logroscino G, Hedayati SS, Strippoli GFM. Association between depression and death in people with CKD: A meta-analysis of cohort studies. American Journal of Kidney Diseases 2013; 62(3):493-505.

Palmer SC, Di Micco L, Razavian M, Craig JC, Ravani P, Perkovic V, Tognoni G, Graziano G, Jardine M, Pellegrini F, Nicolucci A, Webster A, Strippoli GFM. Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis. American Journal of Kidney Diseases 2013;61(1):112-122.

Palmer SC, Craig JC, Navaneethan SD, Tonelli M, Pellegrini F, Strippoli GFM. Benefits and harms of statin therapy for persons with chronic kidney disease. A systematic review and meta-analysis. Annals of Internal Medicine 2012; 157(4):263-75.

Palmer SC, Di Micco L, Razavian M, Craig JC, Perkovic V, Tognoni G, Graziano G, Pellegrini F, Jardine M, Webster A, Nicolucci A, Zoungas S, Strippoli GFM. Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease. Annals of Internal Medicine 2012;156(6):445-59.

Palmer SC, Rabindranath KS, Craig JC, Roderick PJ, Locatelli F, Strippoli GFM. High-flux versus low-flux membranes for end-stage kidney disease. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD005016. DOI: 10.1002/14651858.CD005016.pub2.

Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig J, Elder G, Strippoli GFM. Serum phosphorus, parathyroid hormone, and calcium levels and risks of death and cardiovascular disease in patients with cardiovascular disease. A systematic review and meta-analysis. Journal of the American Medical Association 2011;305(11):1119-27 [with editorial]. Â

Navaneethan SD, Palmer SC, Vecchio M, Craig J, Elder GJ, Strippoli GF. Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database of Systematic Reviews 2011 Feb 16;2:CD006023.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg A, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GFM. Systematic review: Erythropoiesis-stimulating agents in people with chronic kidney disease. Annals of Internal Medicine 2010; 153(1):22-33 [with editorial]

Saglimbene VM, Maione A, Vecchio M, Nicolucci A, Pellegrini F, Navaneethan SD, Palmer S, Craig JC, Triolo G, Procaccini DA, Santoro A, Di Giulio S, Bonifati C, Di Micco L, La Rosa S, Murgo A, Di Toro Mammarella R, Sambati M, D’Ambrosio N, Greco V, Dagostino F, Giannoccaro G, Flammini A, Tedesco M, Boccia E, Di Franco D, Malaguti M, Falco M, Montalto G, Amaru S, Fici M, Amoroso L, D’Alonzo D, Valentini M, Palumbo R, Vischini G, Gori E, Vernaglione L, Casu D, Mandreoli M, Querques M, Hegbrant J, Johnson DW, Tognoni G, Strippoli GF, C E Dose TC. Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol. Trials 2010;11(1):70.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GFM. Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD005633. DOI: 10.1002/14651858.CD005633.pub2.

Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GFM. Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD008175. DOI: 10.1002/14651858.CD008175.

Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. American Journal of Kidney Diseases 2009; 54(4):619-37.

Palmer SC, Nand K, Strippoli GF. Interventions for minimal change disease in adults with nephrotic syndrome. Cochrane Database of Systematic Reviews 2008, Issue 1. Art No.:CD001537. DOI: 10.1002/14651858.CD001537.pub4.

Palmer SC, McGregor DO, Macaskill P, Elder GE, Craig JC, Strippoli GFM. Vitamin D compounds for chronic kidney disease: A systematic review. Annals of Internal Medicine 2007; 147:840-853 [with editorial]

Strippoli GF, Tong A, Palmer SC, Elder G, Craig JC. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients. Cochrane Database Systematic Reviews 2006 Oct 18;(4):CD006254.

Strippoli GFM, Palmer SC, Tong A, Elder G, Craig JC. Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. American Journal of Kidney Diseases 2006, 47(5):715-726.

Palmer SC, Strippoli GFM, McGregor DO. Interventions to prevent bone disease following renal transplantation. American Journal of Kidney Diseases 2005, 45:638-649.

Palmer SC, Strippoli GFM, McGregor DO. Interventions to prevent bone disease following renal transplantation. Cochrane Database of Systematic Reviews, Issue 2, 2005 Chichester, UK: John Wiley & Sons, Ltd.